Paul Clark
Chief Executive Officer bei Lilly ICOS LLC
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Satish Dhanasekaran | M | 51 | 10 Jahre | |
| Robert Funck | M | 62 | 37 Jahre | |
| Jonathan Lord | M | 69 | 10 Jahre | |
| Jean Nye | F | 71 | 25 Jahre | |
| Soon Chai Gooi | M | 63 | 33 Jahre | |
| Scott House | M | - | 34 Jahre | |
| John Chiminski | M | 60 |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 15 Jahre |
| Daniel Podolsky | M | 70 | 9 Jahre | |
| Sue Rataj | F | 67 | 9 Jahre | |
| Scott Leinenweber | M | - | 27 Jahre | |
| Hans Bishop | M | 59 | 7 Jahre | |
| Dow Wilson | M | 64 | 6 Jahre | |
| Mikael Dolsten | M | 65 | 3 Jahre | |
| Michelle Holthaus | F | 50 | 3 Jahre | |
| Paul Lacouture | M | 73 | 5 Jahre | |
| Mala Anand | F | 56 | 5 Jahre | |
| Robert McMahon | M | 55 | 6 Jahre | |
| Joanne Olsen | F | 65 | 5 Jahre | |
| Robert Rango | M | 66 | 9 Jahre | |
| Otis Brawley | M | 64 | 3 Jahre | |
| James Cullen | M | 81 | 10 Jahre | |
| George Scangos | M | 76 | 13 Jahre | |
| Susan Hirsch | F | 71 | 4 Jahre | |
| Charles Dockendorff | M | 69 | 10 Jahre | |
| Guillermo Gualino | M | - | 13 Jahre | |
| Rick Hamada Hamada | M | 65 | 10 Jahre | |
| Philip Boudreau | M | 51 | 27 Jahre | |
| Jenipher Dalton | F | - | 4 Jahre | |
| John Malcolm Hanson | M | 71 |
Grifols Therapeutics, Inc.
 Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 19 Jahre |
| Sergi Roura | M | - |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Mark Wallace | M | 59 | 8 Jahre | |
| Steven O’Day | M | 63 | 3 Jahre | |
| Andrea Wainer | F | - | 27 Jahre | |
| Victoria Wadsworth-Hansen | F | - | 10 Jahre | |
| Mark Pierpoint | M | - | 6 Jahre | |
| Gerald Klein | M | 77 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 19 Jahre |
| Marie Hattar | F | - | 7 Jahre | |
| Henrik Ancher-Jensen | M | 59 | 12 Jahre | |
| Benjamin Leahy Marshall | M | 40 |
Genstar Capital LLC
 Genstar Capital LLC Investment ManagersFinance Genstar Capital LLC engages in provision of investment consulting services. It offers investment advice to financial services, healthcare, industrial, and technology and software industries. The company was founded in 1988 and is headquartered in San Francisco, CA. | 14 Jahre |
| Tom Beermann | M | - | 5 Jahre | |
| Jack Stahl | M | 71 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 10 Jahre |
| Joel E. Abelson | M | 65 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 18 Jahre |
| Jim Engle | M | - |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 19 Jahre |
| Ruedi E. Waeger | M | 80 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Eric Epstein | M | - |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Kari Heerdt | F | 57 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Thomas J. Lynch | M | 73 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 19 Jahre |
| Martin Dawkins | M | - |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Michael Fournel | M | - |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | - |
| Bruce Nogales | M | 67 |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | 19 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| William Sullivan | M | 74 | 16 Jahre | |
| Alexander Arrow | M | 53 | 4 Jahre | |
| George B. Rathmann | M | - |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | 11 Jahre |
| Jeffrey M. Nugent | M | 76 | 1 Jahre | |
| Federico Pignatelli | M | 71 | 23 Jahre | |
| Marie Huber | F | 62 | 13 Jahre | |
| Didier Hirsch | M | 72 | 19 Jahre | |
| Miles White | M | 69 | 37 Jahre | |
| Michael C. Gasparian | M | 65 | 3 Jahre | |
| Elaine R. Leavenworth | F | 65 | 27 Jahre | |
| Harold C. Flynn | M | 58 | 3 Jahre | |
| Scott L. Houlton | M | 57 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 7 Jahre |
| Sam Khichi | M | 57 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 7 Jahre |
| Ron Nersesian | M | 64 | 12 Jahre | |
| Stephen D. Williams | M | 52 | 14 Jahre | |
| Fred B. Parks | M | 76 | 1 Jahre | |
| Brian Yoor | M | 54 | 23 Jahre | |
| David M. Lawrence | M | 83 | 15 Jahre | |
| Kurt R. Nielsen | M | 56 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | - |
| Michael McFadden | M | 57 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 6 Jahre |
| Samuel B. Low | M | - | 1 Jahre | |
| Norman J. Nemoy | M | 84 | 4 Jahre | |
| Sriram Gollapalli | M | - | 7 Jahre | |
| Patrick W. McNallen | M | - | 5 Jahre | |
| Frederick D. Furry | M | 54 | 5 Jahre | |
| Andy Hurley | M | - | 1 Jahre | |
| Hilliard Terry | M | 54 | 13 Jahre | |
| Laura Clague | F | 64 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 2 Jahre |
| John B. Thomas | M | - | 18 Jahre | |
| Jack Schuler | M | 83 | 17 Jahre | |
| Charles W. Silvey | M | 65 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | - |
| Gary L. Wilcox | M | 77 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | 14 Jahre |
| Arthur Higgins | M | 68 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 3 Jahre |
| D. Craig Nordlund | M | 74 | 10 Jahre | |
| David A. L. Owen | M | 85 | - | |
| H. Fuller | M | 85 | - | |
| Roy S. Roberts | M | 84 | - | |
| Duane L. Burnham | M | 82 | 9 Jahre | |
| Mark Templeton | M | 71 | 3 Jahre | |
| Tadataka Yamada | M | 77 | 10 Jahre | |
| Mary Szela | F | 60 | 25 Jahre | |
| Adrian Dillon | M | 70 | 9 Jahre | |
| Alexander Denner | M | 54 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 3 Jahre |
| Steven M. Rauscher | M | 70 | 18 Jahre | |
| A. Barry Rand | M | 79 | 15 Jahre | |
| G. Kirk Raab | M | 88 | 4 Jahre | |
| James Wilson | M | 80 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | 7 Jahre |
| David Milligan | M | 83 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | 28 Jahre |
| Thomas Joseph Dee | M | 60 | 23 Jahre | |
| Evan Kearns | M | 43 | 7 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Paul Clark
- Persönliches Netzwerk
